DE69828586D1 - Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit - Google Patents

Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit

Info

Publication number
DE69828586D1
DE69828586D1 DE69828586T DE69828586T DE69828586D1 DE 69828586 D1 DE69828586 D1 DE 69828586D1 DE 69828586 T DE69828586 T DE 69828586T DE 69828586 T DE69828586 T DE 69828586T DE 69828586 D1 DE69828586 D1 DE 69828586D1
Authority
DE
Germany
Prior art keywords
percuter
azelastinhydrochloride
dispersability
good
absorption ability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69828586T
Other languages
English (en)
Other versions
DE69828586T2 (de
Inventor
Noriko Mizobuchi
Sayuri Seto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teikoku Seiyaku Co Ltd
Original Assignee
Teikoku Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co Ltd filed Critical Teikoku Seiyaku Co Ltd
Publication of DE69828586D1 publication Critical patent/DE69828586D1/de
Application granted granted Critical
Publication of DE69828586T2 publication Critical patent/DE69828586T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69828586T 1997-07-02 1998-06-29 Azelastinhydrochlorid-enthaltende perkutane Formulierung mit guter perkutaner Absorptionsfähigkeit und verringerter Hautreizung Expired - Lifetime DE69828586T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17724297 1997-07-02
JP17724297A JP4138910B2 (ja) 1997-07-02 1997-07-02 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
PCT/JP1998/002953 WO1999001137A1 (fr) 1997-07-02 1998-06-29 Preparation percutanee contenant de l'hydrochlorure d'azelastine, presentant une bonne absorbabilite percutanee et une action d'irritation de la peau reduite

Publications (2)

Publication Number Publication Date
DE69828586D1 true DE69828586D1 (de) 2005-02-17
DE69828586T2 DE69828586T2 (de) 2006-01-19

Family

ID=16027646

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828586T Expired - Lifetime DE69828586T2 (de) 1997-07-02 1998-06-29 Azelastinhydrochlorid-enthaltende perkutane Formulierung mit guter perkutaner Absorptionsfähigkeit und verringerter Hautreizung

Country Status (11)

Country Link
US (1) US6299888B1 (de)
EP (1) EP0958823B1 (de)
JP (1) JP4138910B2 (de)
KR (1) KR20000068285A (de)
AT (1) ATE286732T1 (de)
AU (1) AU746831B2 (de)
CA (1) CA2264693C (de)
DE (1) DE69828586T2 (de)
ES (1) ES2234123T3 (de)
HK (1) HK1021329A1 (de)
WO (1) WO1999001137A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
JP4387639B2 (ja) * 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
EP2564873A4 (de) * 2010-04-28 2013-11-06 Hisamitsu Pharmaceutical Co Mittel zur unterdrückung von hautirritationen und transdermales präparat damit
ES2547888T3 (es) * 2010-04-28 2015-10-09 Hisamitsu Pharmaceutical Co., Inc. Preparación que contiene donepezilo absorbible por vía transdérmica
RU2543326C2 (ru) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения зуда кожи
EA201791321A1 (ru) * 2012-12-19 2018-04-30 Саркоуд Байосайенс Инк. Составы ингибитора lfa-1
US9987361B1 (en) 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE84968T1 (de) * 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
MC2025A1 (fr) 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
ATE107643T1 (de) * 1989-05-05 1994-07-15 Asta Medica Ag Salze des azelastins mit verbesserter löslichkeit.
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤

Also Published As

Publication number Publication date
WO1999001137A1 (fr) 1999-01-14
AU7936098A (en) 1999-01-25
JPH1121240A (ja) 1999-01-26
US6299888B1 (en) 2001-10-09
EP0958823B1 (de) 2005-01-12
CA2264693A1 (en) 1999-01-14
ES2234123T3 (es) 2005-06-16
EP0958823A4 (de) 1999-11-24
KR20000068285A (ko) 2000-11-25
HK1021329A1 (en) 2000-06-09
EP0958823A1 (de) 1999-11-24
CA2264693C (en) 2007-08-28
AU746831B2 (en) 2002-05-02
JP4138910B2 (ja) 2008-08-27
DE69828586T2 (de) 2006-01-19
ATE286732T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
HK1018218A1 (en) Tranilast-containing preparation for external application and method of producing the same
HK1035194A1 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
NZ511201A (en) Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
ITMI992188A0 (it) Combinazione di sostanze attive dotate di proprieta' insetticide ed ac ariche
ATE355269T1 (de) Phenylalaninderivate
EP1114816A4 (de) $g(v)-SUBSTITUIERTE PHENYL-PROSTAGLANDIN-E-DERIVATE UND SIE ALS AKTIVEN BESTANDTEIL ENTHALTENDE MEDIKAMENTE
AU7874001A (en) Novel phenylalanine derivatives
EP0990648A4 (de) Derivate des 4-chinolols und land- und gartenbauwirtschaftliche bakterizide, die diese als aktiven bestandteil enthalten
DE69828586D1 (de) Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
DE69432982D1 (de) Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
EP0965342A4 (de) Zubereitung zur perkutanen verabreichung
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP1269978A3 (de) Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen
DK0454089T3 (da) Percutant absorberbart eperison- eller tolperisonpræparat
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
NO995032D0 (no) Basis-sammensetning for perkutan absorpsjon og perkutant absorberbart preparat inneholdende basis-sammensetningen
EP1234834A4 (de) Derivate des 1,3,4-oxadiazolin-2-on und medikamente, die diese derivate als aktive substanzen enthalten
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same
HUP9802896A3 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition